Pentraxin 3 as a Prognostic Biomarker in Patients with Systemic Inflammation or Infection

Purpose. The long pentraxin 3 (PTX3) is a key component of the humoral arm of the innate immune system. PTX3 is produced locally in response to proinflammatory stimuli. We reviewed the usefulness of systemic levels of PTX3 in critically ill patients with systemic inflammatory response syndrome (SIRS...

Full description

Saved in:
Bibliographic Details
Main Authors: Siguan Liu, Xin Qu, Feng Liu, Chunting Wang
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2014/421429
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850229117194076160
author Siguan Liu
Xin Qu
Feng Liu
Chunting Wang
author_facet Siguan Liu
Xin Qu
Feng Liu
Chunting Wang
author_sort Siguan Liu
collection DOAJ
description Purpose. The long pentraxin 3 (PTX3) is a key component of the humoral arm of the innate immune system. PTX3 is produced locally in response to proinflammatory stimuli. We reviewed the usefulness of systemic levels of PTX3 in critically ill patients with systemic inflammatory response syndrome (SIRS), sepsis, and bacteremia, focusing on its diagnostic and prognostic value. Methods. A PubMed search on PTX3 was conducted. The list of papers was narrowed to original studies of critically ill patients. Eleven papers on original studies of critically ill patients that report on PTX3 in SIRS, sepsis, or bacteremia were identified. Results. Systematic levels of PTX3 have little diagnostic value in critically ill patients with SIRS, sepsis, or bacteremia. Systemic levels of PTX3, however, have superior prognostic power over other commonly used biological markers in these patients. Systemic levels of PTX3 correlate positively with markers of organ dysfunction and severity-of-disease classification system scores. Finally, systemic levels of PTX3 remain elevated in the acute phase and decreased on recovery. Notably, the age of the patients and underlying disease affect systemic levels of PTX3. Conclusions. The diagnostic value of PTX3 is low in patients with sepsis. Systemic levels of PTX3 have prognostic value and may add to prognostication of patients with SIRS or sepsis, complementing severity-of-disease classification systems and other biological markers.
format Article
id doaj-art-1f58265d07f7457b978dba702c99d74a
institution OA Journals
issn 0962-9351
1466-1861
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-1f58265d07f7457b978dba702c99d74a2025-08-20T02:04:20ZengWileyMediators of Inflammation0962-93511466-18612014-01-01201410.1155/2014/421429421429Pentraxin 3 as a Prognostic Biomarker in Patients with Systemic Inflammation or InfectionSiguan Liu0Xin Qu1Feng Liu2Chunting Wang3Department of Critical Care Medicine, Provincial Hospital Affiliated to Shandong University, Jinan 250021, ChinaDepartment of Critical Care Medicine, Provincial Hospital Affiliated to Shandong University, Jinan 250021, ChinaDepartment of Internal Medicine, Rongcheng Traditional Hospital, Weihai 264300, ChinaDepartment of Critical Care Medicine, Provincial Hospital Affiliated to Shandong University, Jinan 250021, ChinaPurpose. The long pentraxin 3 (PTX3) is a key component of the humoral arm of the innate immune system. PTX3 is produced locally in response to proinflammatory stimuli. We reviewed the usefulness of systemic levels of PTX3 in critically ill patients with systemic inflammatory response syndrome (SIRS), sepsis, and bacteremia, focusing on its diagnostic and prognostic value. Methods. A PubMed search on PTX3 was conducted. The list of papers was narrowed to original studies of critically ill patients. Eleven papers on original studies of critically ill patients that report on PTX3 in SIRS, sepsis, or bacteremia were identified. Results. Systematic levels of PTX3 have little diagnostic value in critically ill patients with SIRS, sepsis, or bacteremia. Systemic levels of PTX3, however, have superior prognostic power over other commonly used biological markers in these patients. Systemic levels of PTX3 correlate positively with markers of organ dysfunction and severity-of-disease classification system scores. Finally, systemic levels of PTX3 remain elevated in the acute phase and decreased on recovery. Notably, the age of the patients and underlying disease affect systemic levels of PTX3. Conclusions. The diagnostic value of PTX3 is low in patients with sepsis. Systemic levels of PTX3 have prognostic value and may add to prognostication of patients with SIRS or sepsis, complementing severity-of-disease classification systems and other biological markers.http://dx.doi.org/10.1155/2014/421429
spellingShingle Siguan Liu
Xin Qu
Feng Liu
Chunting Wang
Pentraxin 3 as a Prognostic Biomarker in Patients with Systemic Inflammation or Infection
Mediators of Inflammation
title Pentraxin 3 as a Prognostic Biomarker in Patients with Systemic Inflammation or Infection
title_full Pentraxin 3 as a Prognostic Biomarker in Patients with Systemic Inflammation or Infection
title_fullStr Pentraxin 3 as a Prognostic Biomarker in Patients with Systemic Inflammation or Infection
title_full_unstemmed Pentraxin 3 as a Prognostic Biomarker in Patients with Systemic Inflammation or Infection
title_short Pentraxin 3 as a Prognostic Biomarker in Patients with Systemic Inflammation or Infection
title_sort pentraxin 3 as a prognostic biomarker in patients with systemic inflammation or infection
url http://dx.doi.org/10.1155/2014/421429
work_keys_str_mv AT siguanliu pentraxin3asaprognosticbiomarkerinpatientswithsystemicinflammationorinfection
AT xinqu pentraxin3asaprognosticbiomarkerinpatientswithsystemicinflammationorinfection
AT fengliu pentraxin3asaprognosticbiomarkerinpatientswithsystemicinflammationorinfection
AT chuntingwang pentraxin3asaprognosticbiomarkerinpatientswithsystemicinflammationorinfection